title: Heparin-induced thrombocytopenia: discrepancy between the presence of IgG cross-reacting in vitro with fraxiparine and its successful clinical use.
authors.forename: G
authors.initials: G
authors.lastname: Luzzatto
authors.forename: I
authors.initials: I
authors.lastname: Cordiano
authors.forename: G
authors.initials: G
authors.lastname: Patrassi
authors.forename: F
authors.initials: F
authors.lastname: Fabris
mesh_terms: D000925:Anticoagulants / Q000009:adverse effects / Q000276:immunology* / Q000627:therapeutic use; D003429:Cross Reactions; D006493:Heparin / Q000009:adverse effects*; D006801:Humans; D007074:Immunoglobulin G / Q000276:immunology*; D017762:Nadroparin / Q000276:immunology* / Q000627:therapeutic use; D013921:Thrombocytopenia / Q000139:chemically induced* / Q000276:immunology
chemical_list: D000925:Anticoagulants; D007074:Immunoglobulin G; D017762:Nadroparin; D006493:Heparin